|
IQVIA™ Real-World Insights Bibliography
| Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model |
| Author(s): Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 |
| Affiliations(s): 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany |
Publication(s): JHEOR 2017;5(1):89-108
|
| Document Type(s): Article, |
| Countries: Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK, |
C:
Y: |
Immunology and Vaccination, Infectious disease, Respiratory disease,
2017 |
|
L:
A: |
English
Epidemiological study, Public Health, |
|
 |
| |
| |
| Discovery Benelux: comparison of rosuvastatin with atorvastatin in hypercholesterolaemia. |
| Author(s): Herregods MC, Daubresse JC, Michel G, Lamotte M, Vissers E, Vandenhoven G |
| Affiliations(s): |
Publication(s): Acta Cardiologica, 2008, 63(4): 493-499
|
| Document Type(s): Article, |
| Countries: Belgium, Luxembourg, Luxemburg, Netherlands, |
C:
Y: |
Cardiovascular disease,
2008 |
|
L:
A: |
English
Economic evaluation, |
|
|
| |
| |
|
|
|
